Combined antiviral treatment of a patient with chronic mixed hepatitis (HBV plus HCV)

被引：0
作者：
Fedorchenko, S., V
Martynovich, T. L.
机构：
来源：
TERAPEVTICHESKII ARKHIV | 2006年 / 78卷 / 11期
关键词：
hepatitis; HCV; HBV; interferon; ribaverin; lamivudin; rebetol;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 8 条
[1]  
AROLOV AF, 1990, TERAPEVT ARKH, V11, P11
[2]  
FEDORCHENKO SV, 1991, TERAPEVT ARKH, V11, P55
[3]   Lamivudine resistance in immunocompetent chronic hepatitis B - Incidence and patterns [J].
Honkoop, P ;
Niesters, HGM ;
deMan, RAM ;
Osterhaus, ADME ;
Schalm, SW .
JOURNAL OF HEPATOLOGY, 1997, 26 (06) :1393-1395
[4]   Therapies for hepatitis B: Where to from here? [J].
Locarnini, S .
GASTROENTEROLOGY, 2005, 128 (03) :789-792
[5]   Chronic hepatitis B [J].
Lok, ASF ;
McMahon, BJ .
HEPATOLOGY, 2001, 34 (06) :1225-1241
[6]   Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [J].
Manns, MP ;
McHutchison, JG ;
Gordon, SC ;
Rustgi, VK ;
Shiffman, M ;
Reindollar, R ;
Goodman, ZD ;
Koury, K ;
Ling, MH ;
Albrecht, JK .
LANCET, 2001, 358 (9286) :958-965
[7]   Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial [J].
Schalm, SW ;
Heathcote, J ;
Cianciara, J ;
Farrell, G ;
Sherman, M ;
Willems, B ;
Dhillon, A ;
Moorat, A ;
Barber, J ;
Gray, DF .
GUT, 2000, 46 (04) :562-568
[8]  
1999, MEZHD KONF YEVR ASS, V30, P951
1